Clyde Ellis, MD
Surgery · Las Vegas, NVNPI 1093762908
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Kerecis Limited accounts for 94.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $19,905 and has fallen 81.2% since, to $3,750 in 2025. Among surgery clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 40 payments — averaging $986.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$37K
- TELA Bio, Inc.$886
- Cook Biotech Incorporated$800
- Viiv Healthcare Company$137
- Mallinckrodt Hospital Products Inc.$117
- Davol Inc.$32
- plus $112 from 6 others
What the payments were for
- Consulting fees$16,42542%
- Speaking & faculty fees$11,25029%
- Travel & lodging$5,31513%
- Food & beverage$1,4534%
- Education$5,00013%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 13 | $37,359 |
| TELA Bio, Inc. | 10 | $886 |
| Cook Biotech Incorporated | 1 | $800 |
| Viiv Healthcare Company | 6 | $137 |
| Mallinckrodt Hospital Products Inc. | 1 | $117 |
| Davol Inc. | 2 | $32 |
| AbbVie | 2 | $29 |
| Johnson & Johnson | 1 | $22 |
| Solventum Corporation | 1 | $19 |
| KCI USA, Inc. | 1 | $19 |
| Covidien LP | 1 | $15 |
| Cook Medical LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$39,443 in reported general payments places this provider in the 90th percentile of 209 surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 26 | $585 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $124 |
| Gabapentin | 30 | $68 |
| Naproxen | 25 | $49 |
| Tramadol Hcl | 14 | $10 |
Paid to pharmacies, not to this prescriber.
Other surgery in Las Vegas
- Arthur FuscoLas Vegas$155K
- Ovunc BardakciogluLas Vegas$128K
- Jiashou XuLas Vegas$79K
- Charles ChesnutLas Vegas$76K
- Damon SchroerLas Vegas$74K
- Craig IwamotoLas Vegas$48K
- Arnold ChungLas Vegas$48K
- Stefan ChockLas Vegas$46K
- Matthew JohnsonLas Vegas$40K
- Morgan PomeranzLas Vegas$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.